Cargando…

Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia

The SARS-CoV-2 (COVID-19) is causing a pandemic and potentially fatal disease of global public health concern. Viral infections are known to be associated with coagulation impairment; thus, thrombosis, hemorrhage, or both may occur. Understanding the pathophysiologic mechanisms underlying the develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costanzo, Luca, Palumbo, Francesco Paolo, Ardita, Giorgio, Antignani, Pier Luigi, Arosio, Enrico, Failla, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the Society for Vascular Surgery. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297687/ https://www.ncbi.nlm.nih.gov/pubmed/32561465 http://dx.doi.org/10.1016/j.jvsv.2020.05.018

Ejemplares similares

A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance
por: Chowdhry, Erum, et al.
Publicado: (2021)

Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis
por: Sunseri, Maria, et al.
Publicado: (2018)

Pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: Brondani, Giovanni, et al.
Publicado: (2020)

Thromboembolic Complications in COVID-19 Pneumonia
por: Meiler, Stefanie, et al.
Publicado: (2020)

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
por: Chen, Lanqin, et al.
Publicado: (2023)

Review of Case Study: Chowdhry, Moshman, and Caroll (2021). A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance
por: Brown, Rebecca JL
Publicado: (2022)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers
por: Marietta, Marco, et al.
Publicado: (2020)

COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
por: Zheng, Runhui, et al.
Publicado: (2021)

Coagulopathy and COVID-19
por: Lorini, Ferdinando Luca, et al.
Publicado: (2021)

Pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: Cárdenas Suri, Hisyovi
Publicado: (2020)

Pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: Reines, Brandon P, et al.
Publicado: (2020)

Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
por: Cannegieter, Suzanne C., et al.
Publicado: (2020)

COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020)

Ischemic Stroke and Bilateral Pulmonary Embolism in COVID-19: COVID-Associated Coagulopathy or Heparin-Induced Thrombocytopenia
por: Soliman, Sara, et al.
Publicado: (2022)

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
por: Huang, Jia-Jia, et al.
Publicado: (2023)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Dranichnikov, Paul, et al.
Publicado: (2021)

Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation
por: Senzolo, Marco, et al.
Publicado: (2009)

Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2020)

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: McGonagle, Dennis, et al.
Publicado: (2020)

Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia
por: Blot, Mathieu, et al.
Publicado: (2021)

COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management
por: Manolis, Antonis S., et al.
Publicado: (2020)

Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
por: Yousefi, Parastoo, et al.
Publicado: (2023)

Special Issue “COVID-19 and Venous Thromboembolism”
por: Costanzo, Luca
Publicado: (2022)

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
por: Ahmad, Firdos, et al.
Publicado: (2022)

Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia
por: Mazzaccaro, Daniela, et al.
Publicado: (2020)

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
por: Nicolai, Leo, et al.
Publicado: (2020)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
por: Mangiafico, Marco, et al.
Publicado: (2022)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)

Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database
por: Peng, Jiang-Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_med98nutetia4u1vcdrek509e5